Selumetinib(Koselugo)
KOSELUGO (selumetinib) is indicated for the treatment of pediatric patients aged 2 years and older who have been diagnosed with neurofibromatosis type 1 (NF1) and present with...
CATEGORY NAVIGATION
RELATED ARTICLES
1 / 0
0 in total
Departments
Contact Medical Consultant
Global Drug
Search
Clinical
recruitment
overseas
medical treatment
Remote
consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly
protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved